NMTC on Nasdaq

NEUROONE MEDICAL TECHNOLOGIES Corp

American surgical and medical instruments and apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with InspireMD, Inc., Medinotec Inc. or WORK Medical Technology Group LTD, or pick any stock.

  • TickerNMTC on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersEden Prairie, Minnesota1
  • Incorporated inDE2
  • Business address7599 Anagram Dr, Eden Prairie, Mn 553442
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

(i) diagnostic, ablation and deep brain stimulation technology for brain related conditions such as epilepsy and Parkinson’s disease;3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

56.5%Gross margin4
-46.5%Operating margin4
-39.6%Net margin4
163.5%Revenue growth, 20254
-51.0%Return on equity4
-$2.9MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue24¢$4.0M
  • Research and development31¢$5.0M
  • Selling, general and admin45¢$7.4M

Out of $9.1M in revenue.4 The company lost money this year.

Financial statements

Revenue5674$9.1M in 2025+5007% since 2021
0$2.5M$5.0M$7.5M$10.0M2021: $178.1K$178.1K20212022: $171.2K$171.2K2022−4%2023: $2.0M$2.0M2023+1041%2024: $3.5M$3.5M2024+77%2025: $9.1M$9.1M2025+163%
Gross profit5674$5.1M in 2025
-$2.0M0$2.0M$4.0M$6.0M2021: -$97.7K-$97.7K20212022: -$70.8K-$70.8K2022−28%2023: $456.5K$456.5K20232024: $1.1M$1.1M2024+137%2025: $5.1M$5.1M2025+376%
Operating income895674-$4.2M in 2025−27% since 2019
-$15.0M-$10.0M-$5.0M02019: -$5.8M-$5.8M20192020: -$4.9M-$4.9M2020−16%2021: -$10.2M-$10.2M2021+108%2022: -$10.0M-$10.0M2022−2%2023: -$12.0M-$12.0M2023+19%2024: -$11.9M-$11.9M2024−1%2025: -$4.2M-$4.2M2025−64%
Net income1095674-$3.6M in 2025−22% since 2019
-$15.0M-$10.0M-$5.0M02019: -$4.6M-$4.6M20192020: -$13.6M-$13.6M2020+194%2021: -$9.9M-$9.9M2021−27%2022: -$10.0M-$10.0M2022+1%2023: -$11.9M-$11.9M2023+19%2024: -$12.3M-$12.3M2024+4%2025: -$3.6M-$3.6M2025−71%

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-09-302024-09-30
Product revenue$9.1M$3.5M
Cost of product revenue$4.0M$2.4M
Product gross profit$5.1M$1.1M
Collaborations revenue$3.0M
Selling, general and administrative$7.4M$7.9M
Research and development$5.0M$5.1M
Total operating expenses$12.4M$13.0M
Loss from operations-$4.2M-$11.9M
Fair value change in warrant liability$784.7K-$327.1K
Financing costs-$334.1K-$229.0K
Other income, net$170.5K$125.2K
Loss before income taxes-$3.6M-$12.3M
Net loss-$3.6M-$12.3M
Basic (in Dollars per share)-$0.09-$0.46
Diluted (in Dollars per share)-$0.09-$0.46
Basic (in Shares)40.2M shares26.8M shares
Diluted (in Shares)40.2M shares26.8M shares

Compare NEUROONE MEDICAL TECHNOLOGIES Corp with another company

Leadership

Who has led NEUROONE MEDICAL TECHNOLOGIES Corp, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Lecia Walker2013
  2. Amer Samad2014–2017
  3. David A. Rosa2017–now

President

  1. David A. Rosa2019–now

Chief financial officer

  1. Lecia Walker2013
  2. Ronald W. McClurg2021–2026
  3. Christopher Volker2026–now

Chief operating officer

  1. Christopher Volker2023–now
201520202025
Board members and other officers (16)

Former names

  • Original Source Entertainment, Inc.Oct 4, 2010 to May 22, 20172

Timeline

  1. Jul 24, 2017New chief executive David A. Rosa becomes CEO14
  2. Apr 30, 2014New chief executive Amer Samad becomes CEO15
  3. May 2, 2013New chief executive Lecia Walker becomes CEO16

Filings

336 filings to the SEC since October 2021: 7 annual reports, 16 quarterly reports, 68 major events, 173 insider forms, 16 large holders, 1 private raises, 55 other. The latest 20:

  1. Oct 5, 20268-K CURRENT REPORT EDGAR
  2. Sep 8, 20264 PRIMARY DOCUMENT EDGAR
  3. Aug 28, 20264 PRIMARY DOCUMENT EDGAR
  4. Aug 28, 20264 PRIMARY DOCUMENT EDGAR
  5. Aug 28, 20264 PRIMARY DOCUMENT EDGAR
  6. Aug 28, 20264 PRIMARY DOCUMENT EDGAR
  7. Aug 28, 20264 PRIMARY DOCUMENT EDGAR
  8. Aug 27, 20268-K CURRENT REPORT EDGAR
  9. Aug 13, 202610-Q QUARTERLY REPORT EDGAR
  10. Aug 13, 20268-K CURRENT REPORT EDGAR
  11. Jul 14, 20263 PRIMARY DOCUMENT EDGAR
  12. Jul 14, 2026SCHEDULE 13G/A EDGAR
  13. Jul 2, 20264 PRIMARY DOCUMENT EDGAR
  14. Jun 30, 2026144 EDGAR
  15. Jun 12, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
  16. Jun 12, 20268-K CURRENT REPORT EDGAR
  17. Jun 12, 202610-Q/A AMENDMENT NO. 1 TO FORM 10-Q EDGAR
  18. May 29, 2026SD SPECIALIZED DISCLOSURE REPORT EDGAR
  19. May 29, 2026SD SPECIALIZED DISCLOSURE REPORT EDGAR
  20. May 22, 20268-K CURRENT REPORT EDGAR

The 336 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

31 open-market trades by officers, directors and large owners since October 2021: 10 buys and 21 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 27, 2026Wambeke David J.Chief Business OfficerBuy33,333$2.01$67.0KForm 4
Jun 30, 2026Christianson MarkMarket Development DirectorSale10,000$3.18$31.8KForm 4
Mar 30, 2026Christianson MarkMarket Development DirectorSale15,363$0.74$11.4KForm 4
Mar 13, 2026Christianson MarkMarket Development DirectorSale100$0.80$80Form 4
Mar 12, 2026Christianson MarkMarket Development DirectorSale817$0.80$654Form 4
Mar 11, 2026Christianson MarkMarket Development DirectorSale2,109$0.80$1.7KForm 4
Mar 10, 2026Christianson MarkMarket Development DirectorSale11,611$0.80$9.3KForm 4
Mar 1, 2026Wambeke David J.Chief Business OfficerBuy1,000,000$0.67$670.0KForm 4
Sep 5, 2025Christianson MarkMarket Development DirectorSale30,000$0.74$22.2KForm 4
Jun 4, 2025Christianson MarkMarket Development DirectorSale10,000$0.58$5.8KForm 4
May 22, 2025Christianson MarkMarket Development DirectorSale8,967$0.62$5.6KForm 4
May 21, 2025Christianson MarkMarket Development DirectorSale14$0.65$9Form 4
May 20, 2025Christianson MarkMarket Development DirectorSale3,013$0.66$2.0KForm 4
May 19, 2025Christianson MarkMarket Development DirectorSale8,006$0.67$5.4KForm 4
Apr 4, 2025McClurg Ronald W.Chief Financial OfficerBuy200,000$0.50$100.0KForm 4
Apr 4, 2025Rosa David ACEO & PresidentBuy100,000$0.50$50.0KForm 4
Jun 6, 2024Christianson MarkMarket Development DirectorSale2,189$0.88$1.9KForm 4
Jun 5, 2024Christianson MarkMarket Development DirectorSale25,800$0.88$22.7KForm 4
Dec 27, 2023Christianson MarkMarket Development DirectorSale31,445$1.46$45.9KForm 4
Dec 26, 2023Christianson MarkMarket Development DirectorSale6,848$1.35$9.2KForm 4

All 31 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Aug 2, 2024Raised $276,043 in a private offering of securities Form D: 20 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Bleichroeder LP666,666$2.0M0.4%New
Vanguard Capital Management LLC352,774$1.1M0.0%New
Bard Associates Inc305,428$928.5K0.2%New
Perkins Capital Management Inc244,656$743.8K0.6%New
Geode Capital Management, LLC93,555$284.4K0.0%New
Sio Capital Management, LLC82,767$251.6K0.0%New
Renaissance Technologies LLC70,861$215.4K0.0%New
Vanguard Fiduciary Trust Co49,018$149.0K0.0%New
Essex Investment Management Co LLC43,578$132.5K0.0%New
BlackRock, Inc.25,121$76.4K0.0%New
Northern Trust Corp21,398$65.0K0.0%New
Citadel Advisors LLC15,032$45.7K0.0%New
Susquehanna International Group, Llp13,520$41.1K0.0%New
Belpointe Asset Management LLC12,500$38.0K0.0%New
Legato Capital Management LLC10,273$31.2K0.0%New
UBS Group AG2,623$8.0K0.0%New
Morgan Stanley2,058$6.3K0.0%New
Northwestern Mutual Wealth Management Co361$1.1K0.0%New
Wells Fargo & Company/mn166$5050.0%New
Tower Research Capital LLC (TRC)112$3400.0%New
Barclays PLC76$2310.0%New
Osaic Holdings, Inc.58$1760.0%New
Cambridge Investment Research Advisors, Inc.56,998$1740.0%New
SBI Securities Co., Ltd.13$400.0%−7
Integrated Wealth Concepts LLC8$240.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41